Our results with neuronal cells (CLU and M17 neuroblastoma cells), show that c-Abl inhibition by Nilo treatment leads to significant increase in the basal LC3-II concomitantly deceasing p62 levels compared to control cells (Fig. 5a,b). Here, SQSTM1 is linked to neuroblastoma.